Antengene unveils three pipeline programs at AACR 2026 as AnTenGager platform expands beyond UCB deal
Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
Read More Pharma Industry News Breakthrough Alzheimer’s treatments on the horizon: New drugs and potential vaccine Global Health Update — Promising developments in the fight against Alzheimer’s disease could significantly alter the landscape of… bypharmanewsdailyMarch 21, 2018
